STOCK RESEARCH & ANALYSIS
| Q-o-Q | REVENUES | OPERATING PROFIT | PROFIT AFTER TAX | EPS | Updated : 20-Sep-21 | Details👇 |
| Consolidated | Jun2021 Audited |
Mar2021 Audited |
Dec2020 UnAudited |
Sep2020 UnAudited |
Jun2020 Audited |
Mar2020 Audited |
Dec2019 UnAudited |
Sep2019 UnAudited |
|---|---|---|---|---|---|---|---|---|
| Revenues | ₹9,719 Cr | ₹8,523 Cr | ₹8,837 Cr | ₹8,553 Cr | ₹7,585 Cr | ₹8,185 Cr | ₹8,155 Cr | ₹8,123 Cr |
| Expenses | ₹6,978 Cr | ₹6,475 Cr | ₹6,502 Cr | ₹6,360 Cr | ₹5,821 Cr | ₹6,822 Cr | ₹6,395 Cr | ₹6,342 Cr |
| Operating Income | ₹2,741 Cr | ₹2,048 Cr | ₹2,335 Cr | ₹2,193 Cr | ₹1,764 Cr | ₹1,363 Cr | ₹1,760 Cr | ₹1,781 Cr |
| Other Income | ₹232 Cr | ₹111 Cr | ₹387 Cr | ₹256 Cr | ₹233 Cr | ₹102 Cr | ₹202 Cr | ₹209 Cr |
| Interest | ₹35 Cr | ₹30 Cr | ₹26 Cr | ₹33 Cr | ₹52 Cr | ₹52 Cr | ₹63 Cr | ₹84 Cr |
| Depreciation | ₹503 Cr | ₹553 Cr | ₹532 Cr | ₹499 Cr | ₹496 Cr | ₹575 Cr | ₹547 Cr | ₹473 Cr |
| Profit Before Tax | ₹1,804 Cr | ₹903 Cr | ₹2,163 Cr | ₹1,917 Cr | ₹-2,184 Cr | ₹577 Cr | ₹1,351 Cr | ₹1,433 Cr |
| Profit After Tax | ₹1,409 Cr | ₹848 Cr | ₹1,918 Cr | ₹1,948 Cr | ₹-2,430 Cr | ₹494 Cr | ₹1,024 Cr | ₹1,167 Cr |
| EPS | ₹6.02 | ₹3.73 | ₹7.72 | ₹7.56 | ₹-6.90 | ₹1.67 | ₹3.81 | ₹4.44 |
| Peers & Returns | 1W | 1M | 1Y |
| SUN PHARMACEUTICAL INDUSTRIES | -2.7% | 5.6% | 69.1% |
| DIVIS LABORATORIES | -4.8% | -1.2% | 67.8% |
| DR REDDYS LABORATORIES | -4.9% | -4.4% | -8% |
| CIPLA | -0.9% | -7.1% | 19.3% |
| GLAND PHARMA | -1.5% | -4.6% | NA |
| PIRAMAL ENTERPRISES | -8.1% | -2% | 102.9% |
| CADILA HEALTHCARE | -6% | -10.5% | 20.8% |
| TORRENT PHARMACEUTICALS | -4.6% | -3.9% | 12.5% |
| ALKEM LABORATORIES | -3% | -3.7% | 42.9% |
| Revenues | |
|---|---|
| Q-o-Q | 14.03 % |
| Y-o-Y | 28.13 % |
| Quarters | Revenues | % Change | |
|---|---|---|---|
| Jun2021 | ₹9,719 Cr | 14.03 | |
| Mar2021 | ₹8,523 Cr | -3.55 | |
| Dec2020 | ₹8,837 Cr | 3.32 | |
| Sep2020 | ₹8,553 Cr | 12.76 | |
| Jun2020 | ₹7,585 Cr | -7.33 | |
| Mar2020 | ₹8,185 Cr | 0.37 | |
| Dec2019 | ₹8,155 Cr | 0.39 | |
| Sep2019 | ₹8,123 Cr | - | |
| Operating Profit | |
|---|---|
| Q-o-Q | 33.82 % |
| Y-o-Y | 55.37 % |
| Quarters | Operating Profit | % Change | |
|---|---|---|---|
| Jun2021 | ₹2,741 Cr | 33.82 | |
| Mar2021 | ₹2,048 Cr | -12.25 | |
| Dec2020 | ₹2,335 Cr | 6.44 | |
| Sep2020 | ₹2,193 Cr | 24.31 | |
| Jun2020 | ₹1,764 Cr | 29.45 | |
| Mar2020 | ₹1,363 Cr | -22.54 | |
| Dec2019 | ₹1,760 Cr | -1.21 | |
| Sep2019 | ₹1,781 Cr | - | |
| Operating Margins | |
|---|---|
| Q-o-Q | 17.39 % |
| Y-o-Y | 21.28 % |
| Quarters | Operating Margin% | % Change | |
|---|---|---|---|
| Jun2021 | 28.21% | 17.39 | |
| Mar2021 | 24.03% | -9.05 | |
| Dec2020 | 26.42% | 3.04 | |
| Sep2020 | 25.64% | 10.23 | |
| Jun2020 | 23.26% | 39.70 | |
| Mar2020 | 16.65% | -22.85 | |
| Dec2019 | 21.58% | -1.60 | |
| Sep2019 | 21.93% | - | |
| Profit After Tax(PAT) | |
|---|---|
| Q-o-Q | 66.11 % |
| Y-o-Y | Positive |
| Quarters | Profit After Tax | % Change | |
|---|---|---|---|
| Jun2021 | ₹1,409 Cr | 66.11 | |
| Mar2021 | ₹848 Cr | -55.79 | |
| Dec2020 | ₹1,918 Cr | -1.55 | |
| Sep2020 | ₹1,948 Cr | Positive | |
| Jun2020 | ₹-2,430 Cr | Negative | |
| Mar2020 | ₹494 Cr | -51.71 | |
| Dec2019 | ₹1,024 Cr | -12.30 | |
| Sep2019 | ₹1,167 Cr | - | |
| PAT Margins | |
|---|---|
| Q-o-Q | 45.63 % |
| Y-o-Y | Positive |
| Quarters | PAT Margin(%) | % Change | |
|---|---|---|---|
| Jun2021 | 14.49 % | 45.63 | |
| Mar2021 | 9.95 % | -54.17 | |
| Dec2020 | 21.71 % | -4.70 | |
| Sep2020 | 22.78 % | Positive | |
| Jun2020 | -32.03 % | Negative | |
| Mar2020 | 6.04 % | -51.87 | |
| Dec2019 | 12.55 % | -12.67 | |
| Sep2019 | 14.37 % | - | |
| EPS | |
|---|---|
| Q-o-Q | 61.39 % |
| Y-o-Y | Positive |
| Quarters | EPS | % Change | |
|---|---|---|---|
| Jun2021 | ₹6.02 | 61.39 | |
| Mar2021 | ₹3.73 | -51.68 | |
| Dec2020 | ₹7.72 | 2.12 | |
| Sep2020 | ₹7.56 | Positive | |
| Jun2020 | ₹-6.9 | Negative | |
| Mar2020 | ₹1.67 | -56.17 | |
| Dec2019 | ₹3.81 | -14.19 | |
| Sep2019 | ₹4.44 | - | |
| BSE Indices | 1W | 1M | 1Y |
|---|---|---|---|
| S&P BSE SENSEX | -1.5% | 3.2% | 52.4% |
| S&P BSE SENSEX50 | -2% | 3.1% | 54.5% |
| S&P BSE LARGECAP | -2.3% | 3.1% | 55% |
| S&P BSE 100 LARGECAP TMC | -2.4% | 2.8% | 55.6% |
| S&P BSE 100 ESG INDEX | -2.5% | 3.5% | 55.9% |
| S&P BSE 100 | -2.5% | 2.8% | 55.9% |
| S&P BSE CARBONEX | -2.5% | 3.2% | 55.8% |
| S&P BSE LARGE MIDCAP | -2.7% | 2.9% | 57.9% |
| S&P BSE 200 | -2.7% | 2.8% | 58.9% |
| S&P BSE 250 LARGEMIDCAP | -2.9% | 2.7% | 59.4% |
| S&P BSE 500 | -3.1% | 2.7% | 61.2% |
| S&P BSE ALLCAP | -3.2% | 2.7% | 62.3% |
| S&P BSE GREENEX | -3.5% | 4.4% | 63.5% |
| S&P BSE DIVIDEND STABILITY | -3.8% | 6.3% | 65% |
| S&P BSE HEALTHCARE | -4.4% | -5% | 27.9% |
| S&P BSE 500 SHARIAH | -4.9% | -1.6% | 53.4% |
| MFG | -5% | 1.6% | 49.9% |
| NSE Indices | 1W | 1M | 1Y |
|---|---|---|---|
| NIFTY 50 | -2% | 3.2% | 54.5% |
| NIFTY100 LIQ 15 | -2.1% | 3.9% | 73.7% |
| NIFTY 100 | -2.4% | 2.6% | 55.1% |
| NIFTY LARGE MIDCAP 250 | -2.4% | 4.3% | 70.8% |
| NIFTY500 MULTICAP 50:25:25 | -2.5% | 4.2% | NA |
| NIFTY 200 | -2.8% | 2.8% | 58.7% |
| NIFTY 500 | -3.1% | 2.7% | 60.9% |
| NIFTY50 EQUAL WEIGHT | -3.2% | 2.7% | 71.4% |
| NIFTY HEALTHCARE | -3.7% | -3.1% | NA |
| NIFTY 100 EQUAL WEIGHT | -3.9% | 1.1% | 66.8% |
| NIFTY PHARMA | -4.4% | -2.7% | 19.9% |
#15A, 4th Floor, City Vista, Tower A,
Suite No.984, Fountain Road,
Kharadi, Pune - 411014
Contact Us
support@smart-investing.in
Smart-Investing.in
Pricing
Video Course
Blog
Tools
Screener
Compare
Analyze Portfolio
© 2019 - 2021 Smart-Investing.in. All rights reserved. Built with ❤️ in India
Disclaimer
The information on this site is for educational purposes only and is not investment/trading advice/research and may be delayed.
We don't make any Buy/Sell recommendations and don't give any price targets.
This tool provides statistical summaries of financial data in easy to understand visual form for informational purpose only.
Please do your own research before making any investment decisions.
Equity investments are volatile and high risk in nature. Don't invest more than what you can afford to lose. Past Performance is not indicative of future returns.
We have affiliate relationships with Amazon and Zerodha.
Financial Data Source: Accord Fintech |
Methodology |
Privacy Policy |
Terms & Conditions |
SEBI Registered Research Analyst Registration No : INH000007377 |
Disclosure